Sight Sciences (SGHT) insider sale: 591 shares at $3.37

Sight Sciences, Inc. reporting person Brenton Taylor disclosed a sale of 591 shares of common stock on 10/06/2025.

Accepted by SEC EDGAR 10/08/2025 - 08:12 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Sight Sciences, Inc. reporting person Brenton Taylor disclosed a sale of 591 shares of common stock on 10/06/2025. The sale was executed to cover the reporting person's tax liability related to the vesting of restricted stock units and occurred in multiple transactions at prices ranging from $3.32 to $3.45, with a weighted average price of $3.37. After the reported sale, the reporting person beneficially owned 185,249 shares, held directly. The form bears a signature date of 10/08/2025.

Positive

• Disclosure of tax-withholding sale clarifies the motive for the transaction and reduces ambiguity
• Weighted average price disclosed ($3.37) with the stated price range provides transparency
• Post-transaction holdings reported (185,249 shares) giving clear ownership context

Negative

• Insider disposed of 591 shares, reducing direct ownership and potentially affecting perceived insider conviction
• Sale executed in multiple transactions (prices $3.32–$3.45), which can complicate precise proceeds calculation without further detail

Insider Trade Summary

Net Seller: 591 shares

Net Sell 1 txn

Insider Taylor Brenton

Role EVP, Operations & R&D

Sold 591 shs ($2K)

Type	Security	Shares	Price	Value
Sale	Common Stock	591	$3.37	$2K

Holdings After Transaction: Common Stock — 185,249 shares (Direct)

Footnotes (2)

1. F1. Reflects shares of the Issuer's common stock, par value $0.001 per share, sold to cover the Reporting Person's tax liability in connection with the vesting of restricted stock units.
2. F2. Reflects the weighted average price at which the shares of Common Stock were sold. The shares were sold in multiple transactions at prices ranging from $3.32 to $3.45, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did the Form 4 for Sight Sciences (SGHT) disclose on 10/06/2025?

It disclosed that reporting person Brenton Taylor sold 591 shares on 10/06/2025 to cover tax liability from RSU vesting.

At what prices were the SGHT shares sold?

The shares were sold in multiple transactions at prices ranging from $3.32 to $3.45, with a weighted average of $3.37.

How many SGHT shares does the insider own after the sale?

The filing reports beneficial ownership of 185,249 shares following the reported transactions.

Why were the SGHT shares sold according to the filing?

The filing states the shares were sold to cover the reporting person's tax liability in connection with the vesting of restricted stock units.

When was the Form 4 signed or filed?

The signature on the Form 4 is dated 10/08/2025.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Taylor Brenton

(Last) (First) (Middle)

C/O SIGHT SCIENCES, INC.

4040 CAMPBELL AVE., SUITE 100

(Street)

MENLO PARK CA 94025

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Sight Sciences, Inc. [ SGHT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Operations & R&D

3. Date of Earliest Transaction (Month/Day/Year)
10/06/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/06/2025		S		591(1)	D	$3.37(2)	185,249	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Reflects shares of the Issuer's common stock, par value $0.001 per share, sold to cover the Reporting Person's tax liability in connection with the vesting of restricted stock units.

2. Reflects the weighted average price at which the shares of Common Stock were sold. The shares were sold in multiple transactions at prices ranging from $3.32 to $3.45, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

	/s/Jeremy Hayden, Attorney-in-Fact for Brenton Taylor	10/08/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.